Aurobindo Pharma (NSE:AUROPHARMA, BOM:524804) said its wholly owned subsidiary Apitoria Pharma has incorporated Avogent Lifesciences as a wholly owned subsidiary in India, according to a Tuesday bourse filing.
The new entity will undertake manufacturing and marketing activities in India and overseas and has an initial share capital of 50 million Indian rupees.